Research Article

Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study

Table 3

BMI and tumor histopathologic features in premenopausal Colombian breast cancer patients.

Tumor characteristicsBMI
NormalOverweightObese value

Tumor size , (%)
 TX5 (2.9)4 (2.3)2 (1.5)0.821
 T145 (26.0)39 (22.2)26 (19.7)
 T260 (34.7)59 (33.5)52 (39.4)
 T331 (17.9)39 (22.2)23 (17.4)
 T432 (18.5)35 (19.9)29 (22.0)

Lymph nodes , (%)
 Nx66 (13.7)53 (11)42 (8.7)0.412
 N057 (11.8)70 (14.5)55 (11.4)
 N1–N350 (10.4)53 (11)35 (7.2)

TNM (%)
 I35 (7.2)34 (7.0)22 (4.5)0.847
 II83 (17.26)86 (17.8)68 (14.1)
 III42 (8.7)49 (10.1)37 (7.6)
 IV8 (1.66)4 (0.8)3 (0.6)

Tumor grade
 G136 (20.6)30 (17.1)17 (13.0)0.142
 G269 (39.4)83 (47.4)61 (46.6)
 G341 (23.5)45 (25.7)40 (30.5)

Estrogen receptor status
 Positive132 (75.4)121 (69.1)83 (63.4)0.072
 Negative43 (24.6)54 (30.9)48 (36.6)

Progesterone receptor status
 Positive122 (69.7)111 (63.4)73 (55.7)0.042
 Negative53 (30.3)64 (36.6)58 (44.3)

HER2 status, (%)
 Negative123 (71.1)115 (65.3)95 (72.0)0.384
 Positive42 (24.3)54 (30.7)35 (26.5)
 Unknown8 (4.6)7(4.0)2 (1.5)

Molecular subtype (IHC4)
 Luminal A61 (34.9)57 (32.6)43 (32.8)0.397
 Luminal B, HER 2−38 (21.8)32 (18.3)21 (16.0)
 Luminal B, HER 2+30 (17.1)33 (18.9)19 (14.5)
 Her2-enriched13 (7.4)20 (11.4)16 (12.2)
 Triple negative25 (14.3)26 (14.9)30 (22.9)